AIDS · 2016 · 175 citations · 65 references
Life SciencesImmunologyMicrobiologyInflammationMicrobiome ResearchMucosal ImmunologyGastrointestinal ImmunologyGut MicrobiomeGut MicrobiotaMicrobiome CompositionMucosal ImmunityMucosal InflammationColonic InflammationGut Microbiota EffectsImmune Cell ActivationIntestinal DysbiosisMicrobial TranslocationMicrobiota-immune System InteractionsMucosal DysbiosisMucosal Microbiota
OBJECTIVE: Gut microbial translocation is a major driving force behind chronic immune activation during HIV-1 infection. HIV-1-related intestinal dysbiosis, including increases in mucosa-associated pathobionts, may influence microbial translocation and contribute to mucosal and systemic inflammation. Thus, it is critical to understand the mechanisms by which gut microbes and their metabolic products, such as butyrate, influence immune cell function during HIV-1 infection. DESIGN: A cross-sectional study was performed to compare the relative abundance of butyrate-producing bacterial (BPB) species in colonic biopsies and stool of untreated, chronic HIV-1-infected (n = 18) and HIV-1-uninfected (n = 14) study participants. The effect of exogenously added butyrate on gut T-cell activation and HIV-1 infection was evaluated using an ex-vivo human intestinal cell culture model. METHODS: Species were identified in 16S ribosomal RNA sequence datasets. Ex-vivo isolated lamina propria mononuclear cells were infected with C-C chemokine receptor type 5-tropic HIV-1Bal, cultured with enteric gram-negative bacteria and a range of butyrate doses, and lamina propria T-cell activation and HIV-1 infection levels measured. RESULTS: Relative abundance of total BPB and specifically of Roseburia intestinalis, were lower in colonic mucosa of HIV-1-infected versus HIV-1-uninfected individuals. In HIV-1-infected study participants, R. intestinalis relative abundance inversely correlated with systemic indicators of microbial translocation, immune activation, and vascular inflammation. Exogenous butyrate suppressed enteric gram-negative bacteria-driven lamina propria T-cell activation and HIV-1 infection levels in vitro. CONCLUSION: Reductions in mucosal butyrate from diminished colonic BPB may exacerbate pathobiont-driven gut T-cell activation and HIV replication, thereby contributing to HIV-associated mucosal pathogenesis.
65
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda et al. · Nature · 2013 · 5.3K citations
Daniel N. Frank, Allison L. St. Amand, Robert A. Feldman et al. · Proceedings of the National Academy of Sciences · 2007 · 4.6K citations · Full text
Induction of Colonic Regulatory T Cells by Indigenous <i>Clostridium</i> Species
Koji Atarashi, Takeshi Tanoue, Tatsuichiro Shima et al. · Science · 2010 · 3.6K citations